Developer docs
API playgroundTry for free, no card

Search company profiles

BluPax Pharma

Full company profile

uuid000hhgf

Namestring
BluPax Pharma
Legal namestring
BluPax Pharmaceuticals, LLC
Company typeenum
Private
Founded yearint
2012
Descriptiontext

BluPax Pharmaceuticals, LLC is an independently owned, New Jersey-based wholesale distributor of prescription pharmaceuticals founded in 2012 by Jacob Paskes, Joel Mittelman, and Avraham Yacobi. The company operates from a 40,000 square foot sales and distribution center in Edison, NJ, with offices and field representatives across six states, and is licensed to distribute in all 50 U.S. states, the District of Columbia, and Puerto Rico. BluPax serves thousands of pharmacies across long-term care, independent retail, national chains, specialty pharmacy, hospital, and government customer segments, offering a catalog of over 5,000 SKUs covering all dosage forms and therapeutic categories including Schedule CIII-V controlled substances.

The company purchases directly from 150+ manufacturers (including Pfizer, Moderna, Aurobindo, Prasco, and others) and resells to pharmacy customers through a multi-channel platform that includes a website ordering portal, a progressive mobile web app with barcode scanning, EDI integration, and direct relationships with pharmacy management systems such as PioneerRx, Liberty, SureCost, EzriRx, Pharmacy Marketplace, and UGORx. BluPax is NABP VAWD accredited, DEA licensed, and fully DSCSA compliant (with EPCIS-based data exchange implemented in August 2025), and reports a 99.5% fill rate with free next-day delivery nationwide. The technology stack includes a modern ERP system launched in April 2022, and the company maintains GPO relationships with FPN, Premier, MHA, Innovatix, and Gerimed to offer contracted pricing to member pharmacies.

BluPax generates revenue through a transactional wholesale model, taking margin on pharmaceutical product resales with no subscription requirements, no complex contracts, and no hidden fees. The go-to-market combines dedicated National Account Managers for enterprise and chain accounts with self-service digital ordering for SMB pharmacies, supplemented by fax ordering for legacy customers. The company also runs the PaxPoints loyalty rewards program (1 point per $100 spent on web orders) and a referral program that pays $25-$125 for referred pharmacy accounts. Notable milestones include shipping approximately 2% of all COVID-19 vaccines administered in the United States and being named a 2024 HDA Distribution Management Award finalist for vaccine distribution efforts.

Short descriptiontext

BluPax Pharma is an independently owned, Edison, NJ-based wholesale distributor of prescription pharmaceuticals serving thousands of LTC, retail, specialty, chain, hospital, and government pharmacies across all 50 U.S. states with a 5,000+ SKU catalog sourced from 150+ manufacturers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEdison, United States
HQ citystring
Edison
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical wholesale distribution, prescription drug distribution, pharmacy supply chain, vaccine distribution, drug supply compliance
Industry1 code
PRIMARYCRAOAHAA
Prescription Pharmaceutical (Rx) Wholesale Distribution
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Wholesale Distribution
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Wholesale Distribution
TypeTransaction Fee
Description

BluPax operates as a wholesaler and distributor of prescription pharmaceuticals, generating revenue through the sale of pharmaceutical products to pharmacies and healthcare providers. The company purchases products from manufacturer partners and resells to customers with competitive pricing, no complex contracts or hidden fees. Revenue is transactional per order with no subscription requirements for customers.

blupaxpharma.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales
Pricing details2 tiers
1Standard wholesale pricing with transparent, competitive rates
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Competitive pricing on everyday pharmaceutical needs. No complex contracts or hidden fees. Low order minimum requirements.

blupaxpharma.com
2PaxPoints Rewards Program
ModelTransaction based/ take rateBilling cadenceMonthly
Notes

Earn 1 PaxPoint per $100 spent on web orders. Each point valued at $1. Points automatically added to account balance. Redeemable at checkout for additional savings on future orders. Points expire at end of calendar month earned.

blupaxpharma.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1PaxPoints Rewards Program
Description

Customer rewards program where customers earn PaxPoints on generic orders placed through the website. Points can be redeemed for savings on future orders.

blupaxpharma.com
Core offering1 text field

BluPax Pharma is a B2B wholesaler and distributor of prescription pharmaceuticals, purchasing from 150+ direct manufacturer partners and reselling more than 5,000 SKUs across all dosage forms and therapeutic categories, including CIII-V controlled substances, to LTC, independent retail, specialty, and chain pharmacies, hospitals, and government accounts nationwide. The company supports ordering through its own website and progressive mobile web app, EDI, dedicated National Account Managers, and integrations with third-party pharmacy platforms, with DSCSA-compliant tracking and free next-day delivery on qualifying orders.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 99.5% fill rate achieved through 150+ manufacturer partnerships
+3 more records
Product overview1 text field

BluPax Pharma is an independently owned prescription pharmaceutical wholesaler and distributor serving LTC, independent retail, specialty pharmacies, hospitals, and chains. The company operates primarily as a distribution business rather than a software platform, offering pharmaceutical products across a robust website ordering platform and mobile web app, with EDI and third-party marketplace integrations. Core offerings include the pharmaceutical distribution service (5,000+ SKUs in all dosage forms and therapeutic categories including CIII-V controlled substances), authorized vaccine distribution partnerships (Moderna Spikevax and Pfizer seasonal vaccines), the website ordering platform with features like shopping lists and credit card payments, and the mobile web app with barcode scanning. Add-on services include the PaxPoints customer rewards program and DSCSA compliance services. The company leverages over 150 direct manufacturer partners to achieve a 99.5% fill rate with free next-day delivery.

Product and service5 records
1Pharmaceutical Distribution Services
CategoryPharmaceutical Wholesale Distribution
Description

B2B wholesale and distribution of prescription pharmaceuticals to LTC, independent retail, specialty, and chain pharmacies, hospitals, and government healthcare facilities. Catalog covers 5,000+ SKUs across all dosage forms and therapeutic categories, including CIII-V controlled substances, sourced from 150+ direct manufacturer partners with a 99.5% fill rate and free next-day delivery on qualifying orders.

2Moderna Spikevax Distribution
CategoryVaccine Distribution
Description

Authorized distribution of Moderna's Spikevax COVID-19 vaccine through BluPax's Moderna P.E.R.K. Program partnership. Services direct contract pricing for members of GPOs such as FPN, MHA, Premier, Gerimed, and Innovatix.

3Pfizer Vaccines Distribution
CategoryVaccine Distribution
Description

Authorized distribution of Pfizer's complete line of seasonal vaccines to BluPax customer pharmacies and healthcare providers. Supports direct contract pricing and GPO pricing agreements with quick onboarding, 24-48 hour order fulfillment, and no minimum order quantity requirements.

4PaxPoints Rewards Program
CategoryCustomer Loyalty Program
Description

Customer loyalty rewards program for direct web customers. Customers earn 1 PaxPoint per $100 spent on generic web orders, with each point valued at $1 and redeemable for savings at checkout on future orders. Points automatically added to account balance and expire at the end of the calendar month earned.

5DSCSA Compliance Services
CategoryRegulatory Compliance Services
Description

Drug Supply Chain Security Act compliance support for BluPax customer pharmacies, including EPCIS-based data exchange on every order, Authorized Trading Partner credentialing, and downloadable T3 pedigree documents made available in order details on the website.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

BluPax partnered with LTC@Home in September 2025 to provide members a consistent supply source with competitive pricing. LTC@Home is a national network supporting pharmacies delivering LTC services in home settings. The partnership expands BluPax's reach to more pharmacies servicing the growing long-term care at home segment.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

BluPax is a Moderna P.E.R.K. Program Partner (Preferred Efficient Retail Distribution) and can service direct contract pricing including members of FPN, Premier, MHA, Innovatix, and Gerimed GPOs. P.E.R.K. Program partners share commitment to exceptional service, streamlined onboarding, faster shipping, and distribution expertise.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

BluPax became an authorized distributor for Pfizer vaccines in July 2025, carrying Pfizer's complete line of seasonal vaccines. The company can service direct Pfizer contracts and GPO pricing agreements with 24-48 hour order fulfillment and no minimum order quantity requirements.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

HDA member company representing primary pharmaceutical distributors. BluPax participates in HDA initiatives, was highlighted for decade of growth, and was nominated for the Distribution Management Award for COVID-19 vaccine distribution efforts.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Group Purchasing Organization whose members can access BluPax's services for Moderna and other pharmaceutical products through negotiated pricing agreements.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Healthcare improvement company and GPO whose members can access BluPax services for pharmaceutical distribution.

Strategic tierMinorTypeGTM or Marketing Partner
Description

GPO whose members can access BluPax services for pharmaceutical distribution including Moderna products.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Featured manufacturer partner in June 2026. One of over 150 direct manufacturer partners supplying pharmaceutical products to BluPax catalog.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Featured manufacturer partner in April 2026. Unichem Pharmaceuticals products available through BluPax catalog.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Featured manufacturer partner in July 2026. AiPing Pharma products available through BluPax catalog.

11Prasco LLC
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

BluPax began sourcing directly from Prasco Labs in June 2020, expanding their catalog with Prasco products.

blupaxpharma.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

BluPax maintains relationships with over 150 direct manufacturer partners including Accord Healthcare, Acella Pharmaceuticals, Aiping Pharma, Ajanta Pharma USA, Amneal Pharmaceuticals, Amring Pharmaceuticals, Aurobindo Pharma, and many others. These partnerships enable 99.5% fill rates and comprehensive product catalog.

Strategic tierMinorTypeGTM or Marketing Partner
Description

BluPax featured on Pharmacy Podcast Network with CMO Avi Maidenberg, providing marketing visibility to pharmacy industry audience.

Strategic tierMinorTypeGTM or Marketing Partner
Description

GPO whose members can access BluPax services for pharmaceutical distribution including Moderna products.

Strategic tierMinorTypeGTM or Marketing Partner
Description

GPO focused on geriatric care whose members can access BluPax services for pharmaceutical distribution.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Cardinal Health is the third member of the Big 3 US pharmaceutical wholesalers, providing drug distribution to retail pharmacies, hospitals, and health systems. It competes directly with BluPax for independent and chain pharmacy accounts, particularly through its wholesale distribution segment.

TypeDirect peer
Description

Morris & Dickson is a mid-sized US pharmaceutical wholesale distributor serving independent retail pharmacies, LTC pharmacies, and hospitals — closely matching BluPax's core customer mix. Both companies compete on transparency, service quality, and technology-driven ordering for the independent pharmacy segment.

TypeBroad incumbent
Description

Cencora is one of the Big 3 US pharmaceutical distributors, serving retail pharmacies, hospitals, and health systems. As one of the largest distribution incumbents, Cencora directly competes with BluPax for manufacturer contracts and pharmacy customers, particularly chains and large independents.

4McKesson Corporation
TypeBroad incumbent
Description

McKesson is the largest US pharmaceutical wholesaler, distributing brand and generic drugs to pharmacies, hospitals, and health systems nationwide. While BluPax competes at a smaller scale, both companies offer prescription pharmaceutical wholesale distribution to overlapping customer types (retail pharmacies, hospitals, chains) and compete for manufacturer distribution contracts.

TypeDirect peer
Description

Smith Drug Company (formerly H.D. Smith) is a US pharmaceutical wholesaler focused on independent retail pharmacies, regional chains, and specialty distributors. It is a direct competitor to BluPax in the independent/community pharmacy wholesale segment.

TypeDirect peer
Description

Rochester Drug Cooperative is an independent, member-owned pharmaceutical wholesaler serving independent retail pharmacies. Like BluPax, it focuses on independent retail and LTC customers with competitive pricing and direct customer relationships as the value proposition against the Big 3.

TypeOthers
Description

SureCost is a pharmacy procurement platform that enables independent pharmacies to compare distributor pricing and place orders. SureCost is one of BluPax's integrated third-party ordering platforms, classifying it as an adjacent ecosystem participant rather than a direct distributor.

TypeOthers
Description

Pharmsaver is a third-party pharmaceutical marketplace platform that integrates with multiple distributors including BluPax. While not a direct distributor, it competes for the procurement workflow of independent pharmacies and is included as one of BluPax's third-party ordering integrations.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BluPax Pharma

Pharmaceutical Wholesale Distributionblupaxpharma.com

BluPax Pharma is an independently owned, Edison, NJ-based wholesale distributor of prescription pharmaceuticals serving thousands of LTC, retail, specialty, chain, hospital, and government pharmacies across all 50 U.S. states with a 5,000+ SKU catalog sourced from 150+ manufacturers.

What BluPax Pharma does

BluPax Pharmaceuticals, LLC is an independently owned, New Jersey-based wholesale distributor of prescription pharmaceuticals founded in 2012 by Jacob Paskes, Joel Mittelman, and Avraham Yacobi. The company operates from a 40,000 square foot sales and distribution center in Edison, NJ, with offices and field representatives across six states, and is licensed to distribute in all 50 U.S. states, the District of Columbia, and Puerto Rico. BluPax serves thousands of pharmacies across long-term care, independent retail, national chains, specialty pharmacy, hospital, and government customer segments, offering a catalog of over 5,000 SKUs covering all dosage forms and therapeutic categories including Schedule CIII-V controlled substances.

The company purchases directly from 150+ manufacturers (including Pfizer, Moderna, Aurobindo, Prasco, and others) and resells to pharmacy customers through a multi-channel platform that includes a website ordering portal, a progressive mobile web app with barcode scanning, EDI integration, and direct relationships with pharmacy management systems such as PioneerRx, Liberty, SureCost, EzriRx, Pharmacy Marketplace, and UGORx. BluPax is NABP VAWD accredited, DEA licensed, and fully DSCSA compliant (with EPCIS-based data exchange implemented in August 2025), and reports a 99.5% fill rate with free next-day delivery nationwide. The technology stack includes a modern ERP system launched in April 2022, and the company maintains GPO relationships with FPN, Premier, MHA, Innovatix, and Gerimed to offer contracted pricing to member pharmacies.

BluPax generates revenue through a transactional wholesale model, taking margin on pharmaceutical product resales with no subscription requirements, no complex contracts, and no hidden fees. The go-to-market combines dedicated National Account Managers for enterprise and chain accounts with self-service digital ordering for SMB pharmacies, supplemented by fax ordering for legacy customers. The company also runs the PaxPoints loyalty rewards program (1 point per $100 spent on web orders) and a referral program that pays $25-$125 for referred pharmacy accounts. Notable milestones include shipping approximately 2% of all COVID-19 vaccines administered in the United States and being named a 2024 HDA Distribution Management Award finalist for vaccine distribution efforts.

BluPax Pharma firmographics

Firmographics
Name
BluPax Pharma
Legal name
BluPax Pharmaceuticals, LLC
Website
https://blupaxpharma.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
BluPax Pharma is an independently owned, Edison, NJ-based wholesale distributor of prescription pharmaceuticals serving thousands of LTC, retail, specialty, chain, hospital, and government pharmacies across all 50 U.S. states with a 5,000+ SKU catalog sourced from 150+ manufacturers.
Ownership category
akta.pro rank

BluPax Pharma industry classification

Industry
Product category
Pharmaceutical Wholesale Distribution
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRAOAHAA
Prescription Pharmaceutical (Rx) Wholesale Distribution

Keywords

  • Pharmaceutical wholesale distribution
  • Prescription drug distribution
  • Pharmacy supply chain
  • Vaccine distribution
  • Drug supply compliance

Where BluPax Pharma is headquartered

Location

Headquarters

HQ city
Edison
HQ country
United States
HQ region
North America

Offices3 records

Markets served

BluPax Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Pharmaceutical Wholesale Distribution: BluPax operates as a wholesaler and distributor of prescription pharmaceuticals, generating revenue through the sale of pharmaceutical products to pharmacies and healthcare providers. The company purchases products from manufacturer partners and resells to customers with competitive pricing, no complex contracts or hidden fees. Revenue is transactional per order with no subscription requirements for customers.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goStandard wholesale pricing with transparent, competitive rates
Transaction based/ take rateMonthlyPaxPoints Rewards Program

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

BluPax Pharma product offering

Product offering

Core offering

BluPax Pharma is a B2B wholesaler and distributor of prescription pharmaceuticals, purchasing from 150+ direct manufacturer partners and reselling more than 5,000 SKUs across all dosage forms and therapeutic categories, including CIII-V controlled substances, to LTC, independent retail, specialty, and chain pharmacies, hospitals, and government accounts nationwide. The company supports ordering through its own website and progressive mobile web app, EDI, dedicated National Account Managers, and integrations with third-party pharmacy platforms, with DSCSA-compliant tracking and free next-day delivery on qualifying orders.

Product overview

BluPax Pharma is an independently owned prescription pharmaceutical wholesaler and distributor serving LTC, independent retail, specialty pharmacies, hospitals, and chains. The company operates primarily as a distribution business rather than a software platform, offering pharmaceutical products across a robust website ordering platform and mobile web app, with EDI and third-party marketplace integrations. Core offerings include the pharmaceutical distribution service (5,000+ SKUs in all dosage forms and therapeutic categories including CIII-V controlled substances), authorized vaccine distribution partnerships (Moderna Spikevax and Pfizer seasonal vaccines), the website ordering platform with features like shopping lists and credit card payments, and the mobile web app with barcode scanning. Add-on services include the PaxPoints customer rewards program and DSCSA compliance services. The company leverages over 150 direct manufacturer partners to achieve a 99.5% fill rate with free next-day delivery.

Differentiator

Problem solved

Functional benefit

Brands

  • PaxPoints Rewards Program: Customer rewards program where customers earn PaxPoints on generic orders placed through the website. Points can be redeemed for savings on future orders.

Products and services

  • Pharmaceutical Distribution Services B2B wholesale and distribution of prescription pharmaceuticals to LTC, independent retail, specialty, and chain pharmacies, hospitals, and government healthcare facilities. Catalog covers 5,000+ SKUs across all dosage forms and therapeutic categories, including CIII-V controlled substances, sourced from 150+ direct manufacturer partners with a 99.5% fill rate and free next-day delivery on qualifying orders.
  • Moderna Spikevax Distribution Authorized distribution of Moderna's Spikevax COVID-19 vaccine through BluPax's Moderna P.E.R.K. Program partnership. Services direct contract pricing for members of GPOs such as FPN, MHA, Premier, Gerimed, and Innovatix.
  • Pfizer Vaccines Distribution Authorized distribution of Pfizer's complete line of seasonal vaccines to BluPax customer pharmacies and healthcare providers. Supports direct contract pricing and GPO pricing agreements with quick onboarding, 24-48 hour order fulfillment, and no minimum order quantity requirements.
  • PaxPoints Rewards Program Customer loyalty rewards program for direct web customers. Customers earn 1 PaxPoint per $100 spent on generic web orders, with each point valued at $1 and redeemable for savings at checkout on future orders. Points automatically added to account balance and expire at the end of the calendar month earned.
  • DSCSA Compliance Services Drug Supply Chain Security Act compliance support for BluPax customer pharmacies, including EPCIS-based data exchange on every order, Authorized Trading Partner credentialing, and downloadable T3 pedigree documents made available in order details on the website.

Quantifiable outcome

  • 99.5% fill rate achieved through 150+ manufacturer partnerships
  • +3 more outcomes

Companies that use BluPax Pharma

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles4 records

BluPax Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

Feature4 records

BluPax Pharma partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered core and minor.

  • LTC@HomecoreStrategic or Co-development Partner · 1 September 2025BluPax partnered with LTC@Home in September 2025 to provide members a consistent supply source with competitive pricing. LTC@Home is a national network supporting pharmacies delivering LTC services in home settings. The partnership expands BluPax's reach to more pharmacies servicing the growing long-term care at home segment.
  • ModernacoreChannel Partner/ Reseller/ DistributorBluPax is a Moderna P.E.R.K. Program Partner (Preferred Efficient Retail Distribution) and can service direct contract pricing including members of FPN, Premier, MHA, Innovatix, and Gerimed GPOs. P.E.R.K. Program partners share commitment to exceptional service, streamlined onboarding, faster shipping, and distribution expertise.
  • PfizercoreChannel Partner/ Reseller/ DistributorBluPax became an authorized distributor for Pfizer vaccines in July 2025, carrying Pfizer's complete line of seasonal vaccines. The company can service direct Pfizer contracts and GPO pricing agreements with 24-48 hour order fulfillment and no minimum order quantity requirements.
  • Healthcare Distribution Alliance (HDA)coreStrategic or Co-development PartnerHDA member company representing primary pharmaceutical distributors. BluPax participates in HDA initiatives, was highlighted for decade of growth, and was nominated for the Distribution Management Award for COVID-19 vaccine distribution efforts.
  • FPN (Pharmacy Network)minorGTM or Marketing PartnerGroup Purchasing Organization whose members can access BluPax's services for Moderna and other pharmaceutical products through negotiated pricing agreements.
  • Premier Inc.minorGTM or Marketing PartnerHealthcare improvement company and GPO whose members can access BluPax services for pharmaceutical distribution.
  • MHA (Medical Healthcare Alliance)minorGTM or Marketing PartnerGPO whose members can access BluPax services for pharmaceutical distribution including Moderna products.
  • Aurobindo PharmacoreChannel Partner/ Reseller/ DistributorFeatured manufacturer partner in June 2026. One of over 150 direct manufacturer partners supplying pharmaceutical products to BluPax catalog.
  • Unichem LaboratoriescoreChannel Partner/ Reseller/ DistributorFeatured manufacturer partner in April 2026. Unichem Pharmaceuticals products available through BluPax catalog.
  • AiPing Pharmaceutical Inc.coreChannel Partner/ Reseller/ DistributorFeatured manufacturer partner in July 2026. AiPing Pharma products available through BluPax catalog.
  • Prasco LLCcoreChannel Partner/ Reseller/ DistributorBluPax began sourcing directly from Prasco Labs in June 2020, expanding their catalog with Prasco products.
  • 100+ Manufacturer PartnerscoreChannel Partner/ Reseller/ DistributorBluPax maintains relationships with over 150 direct manufacturer partners including Accord Healthcare, Acella Pharmaceuticals, Aiping Pharma, Ajanta Pharma USA, Amneal Pharmaceuticals, Amring Pharmaceuticals, Aurobindo Pharma, and many others. These partnerships enable 99.5% fill rates and comprehensive product catalog.
  • Pharmacy Podcast NetworkminorGTM or Marketing PartnerBluPax featured on Pharmacy Podcast Network with CMO Avi Maidenberg, providing marketing visibility to pharmacy industry audience.
  • InnovatixminorGTM or Marketing PartnerGPO whose members can access BluPax services for pharmaceutical distribution including Moderna products.
  • GerimedminorGTM or Marketing PartnerGPO focused on geriatric care whose members can access BluPax services for pharmaceutical distribution.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

BluPax Pharma competitors and assessment

Company assessment

Broad incumbents

  • Cardinal Health: Cardinal Health is the third member of the Big 3 US pharmaceutical wholesalers, providing drug distribution to retail pharmacies, hospitals, and health systems. It competes directly with BluPax for independent and chain pharmacy accounts, particularly through its wholesale distribution segment.
  • Cencora (formerly AmerisourceBergen): Cencora is one of the Big 3 US pharmaceutical distributors, serving retail pharmacies, hospitals, and health systems. As one of the largest distribution incumbents, Cencora directly competes with BluPax for manufacturer contracts and pharmacy customers, particularly chains and large independents.
  • McKesson Corporation: McKesson is the largest US pharmaceutical wholesaler, distributing brand and generic drugs to pharmacies, hospitals, and health systems nationwide. While BluPax competes at a smaller scale, both companies offer prescription pharmaceutical wholesale distribution to overlapping customer types (retail pharmacies, hospitals, chains) and compete for manufacturer distribution contracts.

Direct peers

  • Morris & Dickson: Morris & Dickson is a mid-sized US pharmaceutical wholesale distributor serving independent retail pharmacies, LTC pharmacies, and hospitals — closely matching BluPax's core customer mix. Both companies compete on transparency, service quality, and technology-driven ordering for the independent pharmacy segment.
  • Smith Drug Company (H.D. Smith): Smith Drug Company (formerly H.D. Smith) is a US pharmaceutical wholesaler focused on independent retail pharmacies, regional chains, and specialty distributors. It is a direct competitor to BluPax in the independent/community pharmacy wholesale segment.
  • Rochester Drug Cooperative: Rochester Drug Cooperative is an independent, member-owned pharmaceutical wholesaler serving independent retail pharmacies. Like BluPax, it focuses on independent retail and LTC customers with competitive pricing and direct customer relationships as the value proposition against the Big 3.

Others

  • SureCost: SureCost is a pharmacy procurement platform that enables independent pharmacies to compare distributor pricing and place orders. SureCost is one of BluPax's integrated third-party ordering platforms, classifying it as an adjacent ecosystem participant rather than a direct distributor.
  • Pharmsaver: Pharmsaver is a third-party pharmaceutical marketplace platform that integrates with multiple distributors including BluPax. While not a direct distributor, it competes for the procurement workflow of independent pharmacies and is included as one of BluPax's third-party ordering integrations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

BluPax Pharma social profiles

Digital presence

BluPax Pharma compliance and trust

Trust signal

Compliance4 records

BluPax Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BluPax Pharma leadership team

Management profile

Number of profiles

Profiles10 records

BluPax Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BluPax Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BluPax Pharma

What does BluPax Pharma do?

BluPax Pharma is a B2B wholesaler and distributor of prescription pharmaceuticals, purchasing from 150+ direct manufacturer partners and reselling more than 5,000 SKUs across all dosage forms and therapeutic categories, including CIII-V controlled substances, to LTC, independent retail, specialty, and chain pharmacies, hospitals, and government accounts nationwide. The company supports ordering through its own website and progressive mobile web app, EDI, dedicated National Account Managers, and integrations with third-party pharmacy platforms, with DSCSA-compliant tracking and free next-day delivery on qualifying orders.

Is BluPax Pharma a public or private company?

BluPax Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BluPax Pharma founded?

BluPax Pharma was founded in 2012. It employs 11 to 50 people.

Where is BluPax Pharma based?

BluPax Pharma is headquartered in Edison, United States, in the North America region.

How does BluPax Pharma make money?

One revenue line is on record: pharmaceutical Wholesale Distribution.

Who are BluPax Pharma's main competitors?

Broad incumbents on record are Cardinal Health, Cencora (formerly AmerisourceBergen) and McKesson Corporation. Direct peers are Morris & Dickson, Smith Drug Company (H.D. Smith) and Rochester Drug Cooperative. Others are SureCost and Pharmsaver.

Does BluPax Pharma have an API?

No public API is recorded for BluPax Pharma.

What industry is BluPax Pharma in?

BluPax Pharma's product category is Pharmaceutical Wholesale Distribution. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution. Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales